De novo variants in DDX3X account for 1-3% of unexplained intellectual disability (ID), one of the most common causes of ID, in females. Forty-seven patients (44 females, 3 males) have been described. We identified 29 additional individuals carrying 27 unique DDX3X variants in the setting of complex clinical presentations including developmental delay or ID. In addition to previously reported manifestations, rare or novel phenotypes were identified including respiratory problems, congenital heart disease, skeletal muscle mitochondrial DNA depletion, and late-onset neurologic decline. Our findings expand the spectrum of DNA variants and phenotypes associated with DDX3X disorders.
Introduction
Intellectual disability (ID) affects 1-3% of the population, with higher prevalence in males versus females 1 . In males pathogenic variants in over 100 genes on the X chromosome account for 5-10% of ID 2, 3 . Relatively less is known about the number of X-linked genes causing ID in females 4 , but whole exome sequencing (WES) is finding de novo variants in X-linked ID genes in females of all ages [5] [6] [7] .
However, limited information is available regarding such cases. Some of the genes causing ID in females are known to cause disease in males, including PHF6 8 and USP9X, with the latter causing congenital malformations not observed in affected males 9 . Further evidence for gender-specific variant pathogenicity comes from DDX3X located on Xp11.4, with pathogenic de novo variants causing syndromic ID in 39 females; in the same study, three males inherited DDX3X variants from apparently unaffected mothers 10 . Differences in predicted variant severity or X-chromosome inactivation studies from blood DNA did not explain the gender-specific disease expression. Five additional females with DDX3X variants have been described in the literature [11] [12] [13] .
These reports led us to hypothesize that females with de novo variation in DDX3X may show additional clinical phenotypes. We report 29 individuals with DDX3X-related disorders, and provide comprehensive clinical presentations for ten, including the oldest reported individual. These data expand the number of DDX3X pathogenic variants and their associated phenotypic spectrum.
Methods
Variants in DDX3X were identified by WES, performed according to previously described methods 5, 6, 12 , either on a clinical basis at Baylor Genetics (Females 1-24, Males 
Results
Among 4839 (2152 females, 2687 males) patients referred to the Baylor Genetics laboratory for clinical WES with developmental delay (DD) and/or ID, 26 (24 females, 2 males) were found to carry pathogenic or likely pathogenic variants in DDX3X. Through collaboration with the BHCMG, an additional 3 unrelated female cases were identified. The ages at molecular diagnosis ranged from 1 to 47 years (Table S1 ). Twenty-seven unique variants were identified (24 novel and 3 reported previously), including 11 missense, 6 frameshift, 3 splice site, 4 nonsense, and 3 in-frame deletion/duplication changes (Table 1 and Figure 1A and B). In 27 individuals with available parents (26 female and 1 male), the DDX3X variants were confirmed as de novo, supporting the variant pathogenicity. Of the 27 de novo mutations, 7 occurred at CpG dinucleotides. Two de novo variants, c.573_575del (p.I191del) and c.1805G>A (p.R602Q) are mosaic in the proband, with allele fractions of 21% and 14%, respectively ( Table 1) . Congenital heart disease (5/7 who had echo) included atrial/ventricular septal defect, double orifice mitral valve with small patent ductus arteriosus, mild concentric left ventricular hypertrophy and bicuspid aortic valve. In comparison to published data, autism spectrum disorder and other behavior problems and skin abnormalities are underrepresented in our cohort ( Table 2) . For ten subjects, we obtained additional informed consent and provide detailed clinical descriptions (Table S1 ), as well as clinical images for two subjects ( Figure 1C year-old woman (Female 13) with history of global developmental delay, short stature, dysmorphic features, microcephaly and unilateral renal agenesis. She learned to sit at two years of age and walk at eight, and she only learned to say simple words. In her early 40s, she regressed, becoming nonverbal and unable to ambulate or to use her arms. She was found to carry a de novo heterozygous c.1600C>T (p.R534C) likely pathogenic variant in DDX3X ( Table 1 ). The same variant was also observed in Female 14 in our cohort, and a variant involving the same codon (p.R534H) has been reported in a patient with ID 10 . A quadriceps muscle biopsy demonstrated severe mitochondrial and lipid depletion, and reduction in mitochondrial size similar to Female 17. Mitochondrial DNA content in muscle was 26% of the mean value for age and tissue matched controls. A reduction in all mitochondrial respiratory chain complex activities and citrate synthase activity was also observed.
Discussion
Normal RNA metabolism requires the function of RNA helicases (RH), and yet, the exact function of most human RH remains unknown. Genetic studies have begun to address the role of altered RH function in human disease 15 . DDX3X encodes a DEAD-box RNA helicase important in transcription, splicing, RNA transport, and translation 16, 17 . In a diagnostic laboratory referral cohort of 4839 subjects with DD and/or ID, we have identified 26 individuals (24 females, 2 males) with syndromic ID or DD carrying pathogenic or likely pathogenic variants in DDX3X; an additional 3 females were identified through research WES at BHCMG. The overall frequency of pathogenic or likely pathogenic DDX3X variation in our cohort is 0.54% of the total (26/4839) and 1.12% of females (24/2152) , similar to a previous report (0.6% and 1.5% respectively) 10 , confirming DDX3X as one of the most common genetic causes of unexplained ID in females. In our laboratory, DDX3X ranks third among approximately 450 genes for the occurrence of de novo variants, with ARID1B first (43 patients) and ANKRD11 second (29 individuals). In addition to confirming published data, our phenotypic analysis expands the phenotypic spectrum associated with DDX3X variants in females. For instance, we found respiratory problems and congenital heart disease in 5/24 and 5/7 of our subjects, phenotypes not previously described in the original description of DDX3X related disorders 10 , although observed in a subsequent report of two females 11 . We found no evidence for genotype-phenotype correlations between the mutations we identified and age at onset or phenotypic severity. Previously reported individuals ranged in ages from 1 to 33 years. We report the phenotype of a 47-year-old woman (Female 13) who has manifestations consistent with DDX3X disorder and a clinical picture of previously unreported late-onset neurologic decline. The decline is unrelated to intercurrent illness, and her motor function is at least in part responsive to physical therapy. In two individuals (Female 13 and 17), we found skeletal muscle mitochondrial DNA depletion, in a range similar to what is observed in patients with proven mitochondrial DNA depletion syndrome. However, neither case carried pathogenic variants in genes associated with this phenotype. This observation is relevant for at least two reasons. First, if confirmed in additional subjects, it may provide an explanation for the mechanism of some of the observed phenotypes, including the late-onset neurologic decline seen in the oldest of our subjects. Second, DDX3X dysfunction may need to be considered in individuals with unexplained mitochondrial DNA depletion. Although the mechanism of mitochondrial DNA depletion in these individuals remains to be elucidated, pathogenic variants in DDX3X have been shown to regulate Wnt signaling-mediated ventralization in females 10 . Interestingly, Wnt signaling has also been shown to regulate mitochondrial biogenesis 18 Allele fraction for the mosaic variants equals the number of mutant reads divided by the number of total reads.
None of the variants above have been seen in ExAC (http://exac.broadinstitute.org/) or gnomAD 19 .
The allele fraction for the mosaic variants equals the number of mutant reads divided by the number of total reads. pLI=1.00 for DDX3X in the ExAC database, suggesting this gene is intolerant to lossof-function variants in the ExAC cohort. NA: not specified or reported in the published study 10 .
In comparison to published data, autism spectrum disorder and other behavior problems and skin abnormalities are underrepresented in our cohort: 6/27 vs 20/38 (P=6.8x10 -3 ) and 4/27 vs 14/38 (P=2.5x10 -2 ), respectively. 
